NCT06524856 The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
| NCT ID | NCT06524856 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nebraska |
| Condition | Dyspnea |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-10-01 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigators are studying how a device called The Lung Master device can help people breathe better. The investigational device increases the amount of air our lungs can hold, which is important for overall lung health. The Lung Master is not approved by the FDA. The study has two visits approximately one month apart. In the first visit participants will take a spirometry test, particularly forced vital capacity (FVC), to measure volume change in the lungs. Participants will take the investigational device home to use daily, either in the morning or evening. Use will be recorded in a diary. After one month, participants will return for another spirometry test. Each study visit will take about one to two hours to complete.
Eligibility Criteria
Inclusion Criteria: * able to complete the at home portion of the study daily * fall within the age ranges: 19-35 and above 65 years old Exclusion Criteria: * any respiratory or chronic conditions
Contact & Investigator
Farahnaz Fallah Tafti, PhD
PRINCIPAL INVESTIGATOR
University of Nebraska
Frequently Asked Questions
Who can join the NCT06524856 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Dyspnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06524856 currently recruiting?
Yes, NCT06524856 is actively recruiting participants. Contact the research team at annnguyen@unomaha.edu for enrollment information.
Where is the NCT06524856 trial being conducted?
This trial is being conducted at Omaha, United States.
Who is sponsoring the NCT06524856 clinical trial?
NCT06524856 is sponsored by University of Nebraska. The principal investigator is Farahnaz Fallah Tafti, PhD at University of Nebraska. The trial plans to enroll 20 participants.